458 related articles for article (PubMed ID: 29764419)
1. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
[TBL] [Abstract][Full Text] [Related]
2. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
[TBL] [Abstract][Full Text] [Related]
4. Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial.
Kayentao K; Doumbo OK; Pénali LK; Offianan AT; Bhatt KM; Kimani J; Tshefu AK; Kokolomami JH; Ramharter M; de Salazar PM; Tiono AB; Ouédraogo A; Bustos MD; Quicho F; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L
Malar J; 2012 Oct; 11():364. PubMed ID: 23113947
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment.
Roth JM; Sawa P; Omweri G; Osoti V; Makio N; Bradley J; Bousema T; Schallig HDFH; Mens PF
Malar J; 2018 Jun; 17(1):223. PubMed ID: 29866116
[TBL] [Abstract][Full Text] [Related]
6. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Pryce J; Hine P
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
[TBL] [Abstract][Full Text] [Related]
7. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
[TBL] [Abstract][Full Text] [Related]
8. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
9. Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
Hamaluba M; van der Pluijm RW; Weya J; Njuguna P; Ngama M; Kalume P; Mwambingu G; Ngetsa C; Wambua J; Boga M; Mturi N; Lal AA; Khuroo A; Taylor WRJ; Gonçalves S; Miotto O; Dhorda M; Mutinda B; Mukaka M; Waithira N; Hoglund RM; Imwong M; Tarning J; Day NPJ; White NJ; Bejon P; Dondorp AM
Lancet Infect Dis; 2021 Oct; 21(10):1395-1406. PubMed ID: 34111412
[TBL] [Abstract][Full Text] [Related]
10. Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Bukirwa H; Unnikrishnan B; Kramer CV; Sinclair D; Nair S; Tharyan P
Cochrane Database Syst Rev; 2014 Mar; (3):CD006404. PubMed ID: 24596021
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of pyronaridine-artesunate versus artemether-lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial.
Falade CO; Orimadegun AE; Olusola FI; Michael OS; Anjorin OE; Funwei RI; Adedapo AD; Olusanya AL; Orimadegun BE; Mokuolu OA
Malar J; 2023 May; 22(1):154. PubMed ID: 37179349
[TBL] [Abstract][Full Text] [Related]
12. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
[TBL] [Abstract][Full Text] [Related]
13. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Pryce J; Taylor M; Fox T; Hine P
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD006404. PubMed ID: 35726133
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial.
Obonyo CO; Juma EA; Were VO; Ogutu BR
Malar J; 2022 Feb; 21(1):30. PubMed ID: 35109841
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of pyronaridine-artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study.
Ramharter M; Djimde AA; Borghini-Fuhrer I; Miller R; Shin J; Aspinall A; Richardson N; Wibberg M; Fleckenstein L; Arbe-Barnes S; Duparc S
Malar J; 2024 Feb; 23(1):61. PubMed ID: 38418982
[TBL] [Abstract][Full Text] [Related]
16. Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.
Compaoré YD; Zongo I; Somé AF; Barry N; Nikiéma F; Kaboré TN; Ouattara A; Kabré Z; Wermi K; Zongo M; Yerbanga RS; Sagara I; Djimdé A; Ouédraogo JB
Malar J; 2021 Jan; 20(1):64. PubMed ID: 33514368
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.
Duparc S; Borghini-Fuhrer I; Craft CJ; Arbe-Barnes S; Miller RM; Shin CS; Fleckenstein L
Malar J; 2013 Feb; 12():70. PubMed ID: 23433102
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA
Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
Niba PTN; Nji AM; Ali IM; Akam LF; Dongmo CH; Chedjou JPK; Fomboh CT; Nana WD; Oben OLA; Selly-Ngaloumo AA; Moyeh MN; Ngu JA; Ludovic AJ; Aboh PM; Ambani MCE; Omgba PAM; Kotcholi GB; Adzemye LM; Nna DRA; Douanla A; Ango Z; Ewane MS; Ticha JT; Tatah FM; Dinza G; Ndikum VN; Fosah DA; Bigoga JD; Alifrangis M; Mbacham WF
BMC Infect Dis; 2022 Feb; 22(1):166. PubMed ID: 35189818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
